Cargando…

STAT3: Versatile Functions in Non-Small Cell Lung Cancer

Signal Transducer and Activator of Transcription 3 (STAT3) activation is frequently found in non-small cell lung cancer (NSCLC) patient samples/cell lines and STAT3 inhibition in NSCLC cell lines markedly impairs their survival. STAT3 also plays a pivotal role in driving tumor-promoting inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohrherr, Julian, Uras, Iris Z., Moll, Herwig P., Casanova, Emilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281271/ https://www.ncbi.nlm.nih.gov/pubmed/32365499 http://dx.doi.org/10.3390/cancers12051107

Ejemplares similares

Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future
por: Uras, Iris Z., et al.
Publicado: (2020)

A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions
por: Moll, Herwig P., et al.
Publicado: (2019)

JAK–STAT inhibition impairs K‐RAS‐driven lung adenocarcinoma progression
por: Mohrherr, Julian, et al.
Publicado: (2019)

AKT3 drives adenoid cystic carcinoma development in salivary glands
por: Zboray, Katalin, et al.
Publicado: (2017)

Breaking bad family ties: Pan-ERBB blockers inhibit KRAS driven lung tumorigenesis
por: Moll, Herwig P., et al.
Publicado: (2018)

The Role of STAT3 in Non-Small Cell Lung Cancer
por: Harada, Daijiro, et al.
Publicado: (2014)

Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis
por: Grabner, Beatrice, et al.
Publicado: (2015)

miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3
por: Zhao, Zhonghai, et al.
Publicado: (2022)

EGFR transcriptionally upregulates UTX via STAT3 in non-small cell lung cancer
por: Zhou, Lin, et al.
Publicado: (2021)

Targeting STAT3 signaling overcomes gefitinib resistance in non-small cell lung cancer
por: Liu, Zhe, et al.
Publicado: (2021)

STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer
por: Attili, Ilaria, et al.
Publicado: (2018)

Multicellular Effects of STAT3 in Non-small Cell Lung Cancer: Mechanistic Insights and Therapeutic Opportunities
por: Parakh, Sagun, et al.
Publicado: (2021)

Cinobufagin exerts an antitumor effect in non-small-cell lung cancer by blocking STAT3 signaling
por: Yan, Sunshun, et al.
Publicado: (2023)

Targeted Protein Degradation: Clinical Advances in the Field of Oncology
por: Salama, Abdelrahman K. A. A., et al.
Publicado: (2022)

AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer
por: ZHU, Hong, et al.
Publicado: (2018)

HJC0152 suppresses human non–small‐cell lung cancer by inhibiting STAT3 and modulating metabolism
por: Lu, Lu, et al.
Publicado: (2020)

MicroRNA-4500 suppresses tumor progression in non-small cell lung cancer by regulating STAT3
por: Li, Zhi-Ying, et al.
Publicado: (2019)

Flubendazole Elicits Antitumor Effects by Inhibiting STAT3 and Activating Autophagy in Non-small Cell Lung Cancer
por: Xie, Xiaona, et al.
Publicado: (2021)

Stereotactic body radiation therapy for metastatic non-small cell lung cancer: a versatile treatment, repurposed
por: Shen, James L., et al.
Publicado: (2022)

Concerted Suppression of STAT3 and GSK3β Is Involved in Growth Inhibition of Non-Small Cell Lung Cancer by Xanthatin
por: Tao, Li, et al.
Publicado: (2013)

MMPP Attenuates Non-Small Cell Lung Cancer Growth by Inhibiting the STAT3 DNA-Binding Activity via Direct Binding to the STAT3 DNA-Binding Domain
por: Son, Dong Ju, et al.
Publicado: (2017)

Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway
por: Yang, Lehe, et al.
Publicado: (2019)

Effects of combined inhibition of STAT3 and VEGFR2 pathways on the radiosensitivity of non-small-cell lung cancer cells
por: Hu, Chenxi, et al.
Publicado: (2019)

Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non-small cell lung cancer
por: Chang, Liang, et al.
Publicado: (2022)

A dosimetric evaluation of VMAT for the treatment of non‐small cell lung cancer
por: Merrow, Caitlin E., et al.
Publicado: (2012)

PI3K/AKT inhibition induces compensatory activation of the MET/STAT3 pathway in non-small cell lung cancer
por: Bian, Chunan, et al.
Publicado: (2018)

Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC)
por: Codony-Servat, Carles, et al.
Publicado: (2017)

Ubiquitin-specific peptidase 28 enhances STAT3 signaling and promotes cell growth in non-small-cell lung cancer
por: Li, Pengling, et al.
Publicado: (2019)

Reduced RKIP expression levels are associated with frequent non-small cell lung cancer metastasis and STAT3 phosphorylation and activation
por: Wang, Ansheng, et al.
Publicado: (2017)

Saikosaponin D inhibits proliferation and induces apoptosis of non-small cell lung cancer cells by inhibiting the STAT3 pathway
por: Wu, Shibo, et al.
Publicado: (2020)

Ginsenoside Rh2 Inhibits Glycolysis through the STAT3/c-MYC Axis in Non-Small-Cell Lung Cancer
por: Sun, Xiaodan, et al.
Publicado: (2021)

Procyanidins mediates antineoplastic effects against non-small cell lung cancer via the JAK2/STAT3 pathway
por: Wu, Yue, et al.
Publicado: (2021)

LncRNA HAR1A Suppresses the Development of Non-Small Cell Lung Cancer by Inactivating the STAT3 Pathway
por: Ma, Jianqun, et al.
Publicado: (2022)

Effects of Combined Inhibition of STAT3 and VEGFR2 Pathways on the Radiosensitivity of Non-Small-Cell Lung Cancer Cells [Retraction]
Publicado: (2022)

Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer
por: Zhao, Zhucheng, et al.
Publicado: (2022)

TOPS: a versatile software tool for statistical analysis and visualization of combinatorial gene-gene and gene-drug interaction screens
por: Muellner, Markus K, et al.
Publicado: (2014)

Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway
por: Wang, Xiumin, et al.
Publicado: (2016)

IL‐37 inhibits invasion and metastasis in non‐small cell lung cancer by suppressing the IL‐6/STAT3 signaling pathway
por: Jiang, Mingfang, et al.
Publicado: (2018)

Trifolium Flavonoids Overcome Gefitinib Resistance of Non-Small-Cell Lung Cancer Cell by Suppressing ERK and STAT3 Signaling Pathways
por: Wu, Zhiqiang, et al.
Publicado: (2020)

Paeonol Suppresses Proliferation and Motility of Non-Small-Cell Lung Cancer Cells by Disrupting STAT3/NF-κB Signaling
por: Zhang, Lei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o0sh431bb78ofo88cb1iu4403l